Most organisations in Lagos still treat chronic disease as a medical issue that belongs somewhere between employee benefits and occasional wellness campaigns. I think that is a serious strategic mistake. What I see repeatedly is businesses carrying a growing health liability inside their workforce without measuring it properly, pricing it accurately, or recognising how deeply it is already affecting productivity, claims, and workforce stability.
The uncomfortable reality is that Nigeria’s corporate sector is trying to manage twenty-first-century workforce demands while ignoring a disease burden that has fundamentally changed the risk profile of work itself.
The Risk Lagos Is Still Underpricing
The scale of the issue is already well established. The World Health Organization’s Nigeria country profile reported that non-communicable diseases (NCDs) accounted for 29% of all deaths in Nigeria, with cardiovascular disease identified as the largest contributor. WHO also reported premature mortality from NCDs at 22%. Globally, WHO states that NCDs account for 74% of deaths, with most premature NCD deaths occurring in low- and middle-income countries.
For corporate Lagos, that matters far beyond public health policy. It means employers are operating inside a labour market where chronic disease exposure is steadily increasing across the working-age population.
What makes NCDs commercially dangerous is that they rarely arrive as a single dramatic event. They accumulate quietly over years. Hypertension, diabetes, cancer, respiratory disease, and mental health conditions gradually surface through absenteeism, presenteeism, claims inflation, fatigue, reduced performance, and early workforce exit. By the time most organisations notice the pattern, the costs are already embedded across multiple parts of the business.
That is why I describe NCDs as an unpriced liability. Most employers know the issue exists in theory, but very few are measuring its operational impact with the same discipline they apply to financial, cyber, or supply chain risk.
Why Lagos Creates the Perfect Conditions for Chronic Risk
Lagos intensifies nearly every behavioural and environmental driver associated with chronic disease risk. A community study conducted in Lagos reported hypertension prevalence at 35.3%, diabetes at 4.6%, and dyslipidaemia at 47.1%, alongside high levels of smoking, alcohol consumption, and insufficient physical activity among respondents.
Those figures should concern business leaders because they are not abstract epidemiological indicators. They are early signals of future claims volatility and productivity erosion within employer populations.
In practice, the structure of urban work in Lagos compounds the problem further. Long commuting times, sedentary working patterns, irregular eating habits, high stress exposure, limited recovery periods, and fragmented access to preventive care create an environment where chronic risk accumulates almost invisibly.
WHO identifies tobacco use, physical inactivity, harmful alcohol use, unhealthy diets, and air pollution as the principal modifiable risk factors for NCDs. In Lagos, many of those exposures are not separate from work; they are built directly into the daily experience of work itself.
I think this is where many executive teams still underestimate the issue. They continue to frame chronic disease primarily as an individual lifestyle matter, when in reality organisational structures often amplify the risk environment significantly.
There is also a deeper economic dimension that employers cannot afford to ignore. A Nigerian study using data from the 2018–19 Nigeria Living Standard Survey found that households affected by NCDs spent an average of ₦122,313.60 annually on NCD care, while around 30% experienced catastrophic health expenditure and 20% were pushed into or further into impoverishment.
That pressure does not remain outside the workplace. It shows up internally through financial stress, delayed treatment, disengagement, requests for salary advances, rising turnover risk, and deteriorating performance.
Why Employers Are Already Paying the Price
Most HR teams notice the problem first through absence patterns. But absence is usually the visible end-stage of a much larger operational issue.
The more expensive cost is presenteeism. Employees managing chronic conditions often remain at work while dealing with fatigue, medication schedules, untreated symptoms, clinical appointments, and anxiety around treatment affordability. Where insurance coverage is incomplete or healthcare costs remain heavily out-of-pocket, many employees delay intervention until conditions worsen significantly.
That delay increases the probability of longer absences, more complex treatment pathways, and higher-cost claims later.
For finance leaders, the risk extends well beyond medical inflation. Chronic disease gradually weakens workforce output through repeated low-level disruption: reduced productivity, management time spent handling performance concerns, overtime pressures, replacement labour costs, and the loss of institutional knowledge when experienced employees exit earlier than expected.
What makes NCD exposure particularly difficult to manage is its cumulative nature. Unlike a single operational shock, chronic disease develops as a pattern across time. Organisations that fail to track that pattern early usually discover it only when sick leave, utilisation rates, and insurance costs begin rising together.
Risk and insurance leaders face an additional challenge because NCD exposure cuts across multiple benefit and operational silos simultaneously. It affects group life cover, private medical insurance, short-term disability, long-term absence, critical illness exposure, and succession planning for key personnel.
In my experience, many organisations are still looking only at utilisation headlines rather than analysing the underlying disease profile driving those numbers. That creates a dangerous blind spot. The result is that chronic disease gets categorised as general wellbeing spend instead of being treated as a measurable enterprise risk exposure.
What This Means for Leadership
The first implication is that traditional employee benefits are no longer sufficient on their own. A broad health insurance plan is not automatically a workforce risk strategy. If hypertension management, diabetes intervention, cancer screening, mental health support, and behavioural risk reduction are disconnected from workforce analytics, organisations are effectively funding treatment without managing exposure.
The second implication is distributional. NCDs disproportionately affect lower-paid employees because financial constraints often delay diagnosis and treatment. The Nigerian evidence around catastrophic healthcare expenditure makes that very clear. Employees with the least financial resilience are often the least able to sustain uninterrupted work when chronic illness develops.
That has direct implications for retention, engagement, and workforce continuity.
The third implication is strategic positioning. Employers are increasingly competing on the credibility of their workforce proposition, and health is becoming part of that equation. But credibility is not built through wellness branding alone. Employees quickly recognise the difference between performative wellbeing initiatives and serious risk management.
What matters is whether leadership genuinely understands the underlying drivers of chronic disease and is willing to intervene before claims spikes, long absences, or avoidable exits begin damaging the organisation materially.
Strategic Moves Organisations Should Be Making Now
I would recommend five immediate priorities for executive, HR, and risk teams.
First, establish a workforce NCD baseline by integrating claims data, screening outcomes, absence trends, and occupational health information. Organisations cannot price risk they cannot see clearly.
Second, move away from generic wellbeing messaging towards targeted chronic-risk management. Blood pressure, glucose, and BMI screening programmes only create value when they lead to referral pathways, follow-up care, and sustained treatment adherence.
Third, treat financial protection as part of health strategy. The evidence around out-of-pocket healthcare burden in Nigeria demonstrates why incomplete cover weakens prevention and delays intervention. Employers should reassess whether benefit design genuinely reduces barriers to early diagnosis and treatment.
Fourth, improve line manager capability. Managers are often the first people to observe recurring fatigue, attendance drift, behavioural changes, or declining performance linked to chronic health issues. Yet most organisations still provide very limited training in recognising these patterns early.
Fifth, connect health interventions directly to measurable business outcomes. Too many programmes are evaluated using participation metrics alone. The more meaningful indicators are claims trends, long-term absence, productivity movement, retention, and workforce stability.
The Commercial Conclusion
I do not think most employers in Lagos have fully recognised the extent to which they are already carrying chronic disease costs inside their business operations. The exposure is already there. The issue is that many organisations are still describing it incorrectly.
Once leadership teams start treating NCDs as a material workforce liability rather than a peripheral wellbeing concern, the conversation changes completely. It stops being about perks and starts becoming a discussion about enterprise resilience, productivity protection, insurance volatility, and long-term workforce sustainability.
The organisations that move early will have a significant advantage. They will not simply improve employee health outcomes; they will build more stable workforces, reduce operational volatility, and manage workforce risk with far greater precision than competitors still treating chronic disease as somebody else’s problem.